𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The use of Clozapine in Parkinson's disease

✍ Scribed by GONSKI, P. N.

Book ID
119844277
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
102 KB
Volume
24
Category
Article
ISSN
0004-8291

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clozapine in Parkinson's disease
Clozapine in Parkinson's disease
✍ Peter Gonski; P. Auzou; D. Hannequin; N. Moore πŸ“‚ Article πŸ“… 1995 πŸ› The Lancet 🌐 English βš– 316 KB
Parkinson's disease/Parkinson syndromesβ€”
Parkinson's disease/Parkinson syndromesβ€”therapy: Clozapine
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 233 KB

Cabergoline ( C b ) is a U-2 ergot derivative with a long active half-life O 4 8 h ) . In a n open rising dose study we added C b to levodopa+inhibitor in 3 0 parkinsonian patients w i t h motor fluctuations. C h m e a n daily dose w a s 13.3(6-20). given once a day. for a mean period of 1 8 . 3 16-

Clozapine-responsive tremor in Parkinson
Clozapine-responsive tremor in Parkinson's disease
✍ Dr. J. H. Friedman; M. C. Lannon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 451 KB

## Abstract Clozapine is an atypical neuroleptic medication that is free of parkinsonian side effects and that has been reported to ameliorate the tremor of Parkinson's disease. We report (with videotape illustration) the dramatic improvement of severe yet classic rest tremors in one elderly nonpsy

Clozapine for psychosis in Parkinson's d
Clozapine for psychosis in Parkinson's disease
✍ Dr. Ronald F. Pfeiffer; Jasbir Kang; Benjamin Graber; Ruth Hofman; James Wilson πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 321 KB πŸ‘ 1 views

## Abstract The clinical efficacy of clozapine, an atypical antipsychotic, in treating levodopa‐induced hallucinations was investigated in five patients with Parkinson's disease under open label conditions. Two patients could not tolerate clozapine, even in doses as low as 12.5–25 mg daily, because